BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 21830920)

  • 1. Bayesian statistics in medical devices: innovation sparked by the FDA.
    Campbell G
    J Biopharm Stat; 2011 Sep; 21(5):871-87. PubMed ID: 21830920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bayesian approaches in medical device clinical trials: a discussion with examples in the regulatory setting.
    Bonangelino P; Irony T; Liang S; Li X; Mukhi V; Ruan S; Xu Y; Yang X; Wang C
    J Biopharm Stat; 2011 Sep; 21(5):938-53. PubMed ID: 21830924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experience with reviewing Bayesian medical device trials.
    Pennello G; Thompson L
    J Biopharm Stat; 2008; 18(1):81-115. PubMed ID: 18161543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statistical innovations in the medical device world sparked by the FDA.
    Campbell G; Yue LQ
    J Biopharm Stat; 2016; 26(1):3-16. PubMed ID: 26372890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Practical Bayesian design and analysis for drug and device clinical trials.
    Hobbs BP; Carlin BP
    J Biopharm Stat; 2008; 18(1):54-80. PubMed ID: 18161542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of Clinical Studies Conducted Over the Total Product Life Cycle of High-Risk Therapeutic Medical Devices Receiving FDA Premarket Approval in 2010 and 2011.
    Rathi VK; Krumholz HM; Masoudi FA; Ross JS
    JAMA; 2015 Aug; 314(6):604-12. PubMed ID: 26262798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The nightmare of FDA clearance/approval to market: perception or reality?
    Tylenda CA
    Technol Health Care; 1996 Sep; 4(3):259-67. PubMed ID: 8931236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How do regulatory agencies ensure the release of a safe medical device?
    Haggar B
    Clin Perform Qual Health Care; 1999; 7(2):100-3. PubMed ID: 10747561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New FDA draft guidance on premarket submissions.
    Donawa ME
    Med Device Technol; 1999 Oct; 10(8):12-4. PubMed ID: 10724773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Missing data in the regulation of medical devices.
    Campbell G; Pennello G; Yue L
    J Biopharm Stat; 2011 Mar; 21(2):180-95. PubMed ID: 21390995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medical devices; exemptions from premarket notification and reserved devices; class I--FDA. Notice.
    Fed Regist; 1998 Feb; 63(21):5387-93. PubMed ID: 10177333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FDA marketing claims, and the practitioner.
    Runner S
    J Evid Based Dent Pract; 2006 Mar; 6(1):19-23. PubMed ID: 17138391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medical devices; medical device user facility and manufacturer reporting, certification and registration; Office of Management and Budget approval; extension of effective date--FDA. Final rule; notification of approval of information collection requirements.
    Fed Regist; 1996 Apr; 61(71):16043-5. PubMed ID: 10157704
    [No Abstract]   [Full Text] [Related]  

  • 14. The FDA and the medical device approval process.
    Guez G; Garg A
    Dent Implantol Update; 2012 May; 23(5):33-7. PubMed ID: 22594003
    [No Abstract]   [Full Text] [Related]  

  • 15. Bayesian optimal adaptive designs for delayed-response dose-finding studies.
    Li W; Fu H
    J Biopharm Stat; 2011 Sep; 21(5):888-901. PubMed ID: 21830921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FDA modernization act of 1997: guidance on medical device tracking; availability--FDA. Notice.
    Fed Regist; 1998 Mar; 63(42):10640-1. PubMed ID: 10177505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medical devices containing materials derived from animal sources (except for in vitro diagnostic devices), guidance for FDA reviewers and industry; availability--FDA. Notice.
    Fed Regist; 1998 Nov; 63(215):60009-10. PubMed ID: 10187389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ensuring safe and effective medical devices.
    Feigal DW; Gardner SN; McClellan M
    N Engl J Med; 2003 Jan; 348(3):191-2. PubMed ID: 12529457
    [No Abstract]   [Full Text] [Related]  

  • 19. The critical path to medical innovation.
    Williams D
    Med Device Technol; 2004 Jun; 15(5):8-10. PubMed ID: 15285478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medical devices; device tracking; new orders to manufacturers--FDA. Notice.
    Fed Regist; 1998 Mar; 63(42):10638-40. PubMed ID: 10177504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.